| 000915 (2017) |
Barry K. Logan [États-Unis] ; Amanda L A. Mohr [États-Unis] ; Melissa Friscia [États-Unis] ; Alex J. Krotulski [États-Unis] ; Donna M. Papsun [États-Unis] ; Sherri L. Kacinko [États-Unis] ; Jeri D. Ropero-Miller [États-Unis] ; Marilyn A. Huestis [États-Unis] | Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review. |
| 000588 (2019) |
Alex J. Krotulski [États-Unis] ; Amanda L A. Mohr [États-Unis] ; Sherri L. Kacinko [États-Unis] ; Melissa F. Fogarty [États-Unis] ; Sarah A. Shuda [États-Unis] ; Francis X. Diamond [États-Unis] ; William A. Kinney [États-Unis] ; M J Menendez [États-Unis] ; Barry K. Logan [États-Unis] | 4F-MDMB-BINACA: A New Synthetic Cannabinoid Widely Implicated in Forensic Casework. |
| 000167 (2020) |
Alex J. Krotulski [États-Unis] ; Donna M. Papsun [États-Unis] ; Sherri L. Kacinko [États-Unis] ; Barry K. Logan [États-Unis] | Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework. |
| 000218 (2020) |
Amanda L A. Mohr [États-Unis] ; Melissa F. Fogarty [États-Unis] ; Alex J. Krotulski [États-Unis] ; Barry K. Logan [États-Unis] | Evaluating Trends in Novel Psychoactive Substances Using a Sentinel Population of Electronic Dance Music Festival Attendees. |
| 000536 (2019) |
Juseon Lee [Corée du Sud] ; Alex J. Krotulski [États-Unis] ; Melissa F. Fogarty [États-Unis] ; Donna M. Papsun [États-Unis] ; Barry K. Logan [États-Unis] | Chromatographic separation of the isobaric compounds cyclopropylfentanyl, crotonylfentanyl, methacrylfentanyl, and para-methylacrylfentanyl for specific confirmation by LC-MS/MS. |
| 000608 (2018) |
Amanda L A. Mohr [États-Unis] ; Melissa Friscia [États-Unis] ; Jillian K. Yeakel [États-Unis] ; Barry K. Logan [États-Unis] | Use of synthetic stimulants and hallucinogens in a cohort of electronic dance music festival attendees. |
| 000630 (2018) |
Alex J. Krotulski [États-Unis] ; Amanda L A. Mohr [États-Unis] ; Melissa F. Fogarty [États-Unis] ; Barry K. Logan [États-Unis] | The Detection of Novel Stimulants in Oral Fluid from Users Reporting Ecstasy, Molly and MDMA Ingestion. |
| 000702 (2018) |
Alex J. Krotulski [États-Unis] ; Donna M. Papsun [États-Unis] ; Bruno S. De Martinis [États-Unis, Brésil] ; Amanda L A. Mohr [États-Unis] ; Barry K. Logan [États-Unis] | N-Ethyl Pentylone (Ephylone) Intoxications: Quantitative Confirmation and Metabolite Identification in Authentic Human Biological Specimens. |
| 000706 (2018) |
Alex J. Krotulski [États-Unis] ; Amanda L A. Mohr [États-Unis] ; Donna M. Papsun [États-Unis] ; Barry K. Logan [États-Unis] | Metabolism of novel opioid agonists U-47700 and U-49900 using human liver microsomes with confirmation in authentic urine specimens from drug users. |
| 000746 (2018) |
Alex J. Krotulski [États-Unis] ; Amanda L A. Mohr [États-Unis] ; Melissa Friscia [États-Unis] ; Barry K. Logan [États-Unis] | Field Detection of Drugs of Abuse in Oral Fluid Using the Alere™ DDS®2 Mobile Test System with Confirmation by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS). |
| 000748 (2018) |
Alex J. Krotulski [États-Unis] ; Donna M. Papsun [États-Unis] ; Melissa Friscia [États-Unis] ; Jennifer L. Swartz [États-Unis] ; Brian D. Holsey [États-Unis] ; Barry K. Logan [États-Unis] | Fatality Following Ingestion of Tetrahydrofuranylfentanyl, U-49900 and Methoxy-Phencyclidine. |
| 000781 (2018) |
Alex J. Krotulski [États-Unis] ; Amanda L A. Mohr [États-Unis] ; Donna M. Papsun [États-Unis] ; Barry K. Logan [États-Unis] | Dibutylone (bk-DMBDB): Intoxications, Quantitative Confirmations and Metabolism in Authentic Biological Specimens. |
| 000D45 (2016) |
Amanda L A. Mohr [États-Unis] ; Melissa Friscia [États-Unis] ; Donna Papsun [États-Unis] ; Sherri L. Kacinko [États-Unis] ; David Buzby [États-Unis] ; Barry K. Logan [Oman, États-Unis] | Analysis of Novel Synthetic Opioids U-47700, U-50488 and Furanyl Fentanyl by LC-MS/MS in Postmortem Casework. |
| 000203 (2020) |
Donna M. Papsun [États-Unis] ; Alex J. Krotulski [États-Unis] ; Joe Homan [États-Unis] ; Keith D H. Temporal [États-Unis] ; Barry K. Logan [États-Unis] | Flualprazolam Blood Concentrations in 197 Forensic Investigation Cases. |
| 000215 (2020) |
Alex J. Krotulski [États-Unis] ; Sandra C. Bishop-Freeman [États-Unis] ; Amanda L A. Mohr [États-Unis] ; Barry K. Logan [États-Unis] | Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds-A Stability Assessment. |
| 000225 (2020) |
Alex J. Krotulski [États-Unis] ; Amanda L A. Mohr [États-Unis] ; Barry K. Logan [États-Unis] | Emerging Synthetic Cannabinoids: Development and Validation of a Novel Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry Assay for Real-Time Detection. |
| 000258 (2020) |
Alex J. Krotulski [États-Unis] ; Amanda L A. Mohr [États-Unis] ; Francis X. Diamond [États-Unis] ; Barry K. Logan [États-Unis] | Detection and characterization of the new synthetic cannabinoid APP-BINACA in forensic casework. |
| 000454 (2019) |
Melissa F. Fogarty [États-Unis] ; Barry K. Logan [États-Unis] ; Francis X. Diamond [États-Unis] ; Lynsey Mickolas [États-Unis] ; Sarah A. Shuda [États-Unis] ; Alex J. Krotulski [États-Unis] | Letter to Editor-NBOH Derivatization for the Analysis of Seized Drug Casework by GC-MS. |
| 000581 (2019) |
Brittany P. Chapman ; Jeffrey T. Lai ; Alex J. Krotulski [États-Unis] ; Melissa F. Fogarty [États-Unis] ; Matthew K. Griswold [États-Unis] ; Barry K. Logan [États-Unis] ; Kavita M. Babu | A Case of Unintentional Opioid (U-47700) Overdose in a Young Adult After Counterfeit Xanax Use. |
| 000645 (2018) |
Matthew K. Griswold [États-Unis] ; Peter R. Chai [États-Unis] ; Alex J. Krotulski [États-Unis] ; Melissa Friscia [États-Unis] ; Brittany Chapman [États-Unis] ; Edward W. Boyer [États-Unis] ; Barry K. Logan [États-Unis] ; Kavita M. Babu [États-Unis] | Self-identification of nonpharmaceutical fentanyl exposure following heroin overdose. |
| 000828 (2018) |
Melissa F. Fogarty [États-Unis] ; Donna M. Papsun [États-Unis] ; Barry K. Logan [États-Unis] | Analysis of cis and trans 3-methylfentanyl by liquid chromatography-high resolution mass spectrometry and findings in forensic toxicology casework. |
| 000829 (2018) |
Melissa F. Fogarty [États-Unis] ; Donna M. Papsun [États-Unis] ; Barry K. Logan [États-Unis] | Analysis of Fentanyl and 18 Novel Fentanyl Analogs and Metabolites by LC-MS-MS, and report of Fatalities Associated with Methoxyacetylfentanyl and Cyclopropylfentanyl. |
| 000A92 (2017) |
Matthew K. Griswold [États-Unis] ; Peter R. Chai [États-Unis] ; Alex J. Krotulski [États-Unis] ; Melissa Friscia [États-Unis] ; Brittany P. Chapman [États-Unis] ; Neha Varma [États-Unis] ; Edward W. Boyer [États-Unis] ; Barry K. Logan [États-Unis] ; Kavita M. Babu [États-Unis] | A Novel Oral Fluid Assay (LC-QTOF-MS) for the Detection of Fentanyl and Clandestine Opioids in Oral Fluid After Reported Heroin Overdose. |
| 000049 (2020) |
Alex J. Krotulski [États-Unis] ; Annelies Cannaert [Belgique] ; Christophe Stove [Belgique] ; Barry K. Logan [États-Unis] | The next generation of synthetic cannabinoids: Detection, activity, and potential toxicity of pent-4en and but-3en analogues including MDMB-4en-PINACA. |
| 000083 (2020) |
Alex J. Krotulski [États-Unis] ; Susan Jansen Varnum [États-Unis] ; Barry K. Logan [États-Unis] | Sample Mining and Data Mining: Combined Real-Time and Retrospective Approaches for the Identification of Emerging Novel Psychoactive Substances. |
| 000388 (2019) |
Sherri L. Kacinko [États-Unis] ; Donna M. Papsun [États-Unis] | The Evolving Landscape of Designer Drugs. |
| 000522 (2019) |
Taís R. Fiorentin ; Alex J. Krotulski ; David M. Martin ; Thom Browne [Sri Lanka] ; Jeremy Triplett ; Trisha Conti ; Barry K. Logan | Detection of Cutting Agents in Drug-Positive Seized Exhibits within the United States. |
| 000663 (2018) |
Barry K. Logan [États-Unis] ; Amanda L. D'Orazio [États-Unis] ; Amanda L A. Mohr [États-Unis] ; Jennifer F. Limoges [États-Unis] ; Amy K. Miles [États-Unis] ; Colleen E. Scarneo [États-Unis] ; Sarah Kerrigan [États-Unis] ; Laura J. Liddicoat [États-Unis] ; Karen S. Scott [États-Unis] ; Marilyn A. Huestis [États-Unis] | Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities-2017 Update. |
| 000837 (2018) |
Annelies Cannaert [Belgique] ; Lakshmi Vasudevan [Belgique] ; Melissa Friscia [États-Unis] ; Amanda L A. Mohr [États-Unis] ; Sarah M R. Wille [Belgique] ; Christophe P. Stove [Belgique] | Activity-Based Concept to Screen Biological Matrices for Opiates and (Synthetic) Opioids. |
| 000962 (2017) |
Keith-Dane H. Temporal [États-Unis] ; Karen S. Scott [États-Unis] ; Amanda L A. Mohr [États-Unis] ; Barry K. Logan [États-Unis] | Metabolic Profile Determination of NBOMe Compounds Using Human Liver Microsomes and Comparison with Findings in Authentic Human Blood and Urine. |
| 001115 (2014) |
Theresa M. Scott [États-Unis] ; Jillian K. Yeakel ; Barry K. Logan | Identification of mitragynine and O-desmethyltramadol in Kratom and legal high products sold online. |
| 001137 (2014) |
Amanda L A. Mohr [États-Unis] ; Bill Ofsa [États-Unis] ; Alyssa Marie Keil [États-Unis] ; John R. Simon [États-Unis] ; Matthew Mcmullin [États-Unis] ; Barry K. Logan [Oman] | Enzyme-linked immunosorbent assay (ELISA) for the detection of use of the synthetic cannabinoid agonists UR-144 and XLR-11 in human urine. |
| 001149 (2014) |
Barry K. Logan [Oman] ; Amanda L A. Mohr [États-Unis] ; Stephen K. Talpins [États-Unis] | Detection and prevalence of drug use in arrested drivers using the Dräger Drug Test 5000 and Affiniton DrugWipe oral fluid drug screening devices. |
| 001251 (2013) |
Barry K. Logan [États-Unis] ; Kayla J. Lowrie ; Jennifer L. Turri ; Jillian K. Yeakel ; Jennifer F. Limoges ; Amy K. Miles ; Colleen E. Scarneo ; Sarah Kerrigan ; Laurel J. Farrell | Recommendations for toxicological investigation of drug-impaired driving and motor vehicle fatalities. |
| 001336 (2013) |
Jillian K. Yeakel [États-Unis] ; Barry K. Logan | Butalbital and driving impairment. |
| 001338 (2013) |
Jillian K. Yeakel [États-Unis] ; Barry K. Logan | Blood synthetic cannabinoid concentrations in cases of suspected impaired driving. |
| 001459 (2012) |
Barry K. Logan [États-Unis] ; Jillian K. Yeakel ; Gary Goldfogel ; Michael P. Frost ; Greg Sandstrom ; Dennis J. Wickham | Dextromethorphan abuse leading to assault, suicide, or homicide. |
| 001586 (2011) |
Sherri L. Kacinko [États-Unis] ; Allan Xu ; Joseph W. Homan ; Matthew M. Mcmullin ; Donna M. Warrington ; Barry K. Logan | Development and validation of a liquid chromatography-tandem mass spectrometry method for the identification and quantification of JWH-018, JWH-073, JWH-019, and JWH-250 in human whole blood. |
| 000131 (2020) |
Brandon C. Presley [États-Unis] ; Barry K. Logan [États-Unis] ; Susan A. Jansen-Varnum [États-Unis] | Phase I metabolism of synthetic cannabinoid receptor agonist PX-1 (5F-APP-PICA) via incubation with human liver microsomes and UHPLC-HRMS. |
| 000160 (2020) |
Brandon C. Presley [États-Unis] ; Marisol S. Castaneto [États-Unis] ; Barry K. Logan [États-Unis] ; Susan A. Jansen-Varnum [États-Unis] | Metabolic profiling of synthetic cannabinoid 5F-ADB and identification of metabolites in authentic human blood samples via human liver microsome incubation and ultra-high-performance liquid chromatography/high-resolution mass spectrometry. |
| 000178 (2020) |
Brandon C. Presley [États-Unis] ; Barry K. Logan [États-Unis] ; Susan A. Jansen-Varnum [États-Unis] | In Vitro Metabolic Profile Elucidation of Synthetic Cannabinoid APP-CHMINACA (PX-3). |
| 000306 (2020) |
Brandon C. Presley [États-Unis] ; Marisol S. Castaneto [États-Unis] ; Barry K. Logan [États-Unis] ; Susan A. Jansen-Varnum [États-Unis] | Assessment of synthetic cannabinoid FUB-AMB and its ester hydrolysis metabolite in human liver microsomes and human blood samples using UHPLC-MS/MS. |
| 000308 (2020) |
Taís R. Fiorentin [États-Unis] ; Barry K. Logan [États-Unis] ; David M. Martin [États-Unis] ; Thom Browne [Sri Lanka] ; Eric F. Rieders [États-Unis] | Assessment of a portable quadrupole-based gas chromatography mass spectrometry for seized drug analysis. |
| 000312 (2020) |
Taís Regina Fiorentin [États-Unis] ; Barry K. Logan [États-Unis] | Analytical findings in used syringes from a syringe exchange program. |
| 000357 (2019) |
Kevin M. Legg [États-Unis] ; Laura M. Labay [États-Unis] ; Sally S. Aiken [États-Unis] ; Barry K. Logan [États-Unis] | Validation of a Fully Automated Immunoaffinity Workflow for the Detection and Quantification of Insulin Analogs by LC-MS-MS in Postmortem Vitreous Humor. |
| 000381 (2019) |
Donna M. Papsun [États-Unis] ; Ayako Chan-Hosokawa [États-Unis] ; Laura Friederich [États-Unis] ; Justin Brower [États-Unis] ; Kristopher Graf [États-Unis] ; Barry Logan [États-Unis] | The Trouble With Kratom: Analytical and Interpretative Issues Involving Mitragynine. |
| 000385 (2019) |
Jayne B. Morrow [États-Unis] ; Jeri D. Ropero-Miller [États-Unis] ; Megan L. Catlin [États-Unis] ; Agnes D. Winokur [États-Unis] ; Amy B. Cadwallader [États-Unis] ; Jessica L. Staymates [États-Unis] ; Shannan R. Williams [États-Unis] ; Jonathan G. Mcgrath [États-Unis] ; Barry K. Logan [États-Unis] ; Michael M. Mccormick [États-Unis] ; Kurt B. Nolte [États-Unis] ; Thomas P. Gilson [États-Unis] ; M J Menendez [États-Unis] ; Bruce A. Goldberger [États-Unis] | The Opioid Epidemic: Moving Toward an Integrated, Holistic Analytical Response. |
| 000418 (2019) |
Sherri L. Kacinko [États-Unis] ; Joseph W. Homan [États-Unis] | Quantification of Designer Opioids by Liquid Chromatography-Tandem Mass Spectrometry. |
| 000466 (2019) |
Brandon C. Presley [États-Unis] ; Barry K. Logan [États-Unis] ; Susan A. Jansen-Varnum [États-Unis] | In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry. |
| 000475 (2019) |
Annelies Cannaert [Belgique] ; Marie Deventer [Belgique] ; Melissa Fogarty [États-Unis] ; Amanda L A. Mohr [États-Unis] ; Christophe P. Stove [Belgique] | Hide and Seek: Overcoming the Masking Effect of Opioid Antagonists in Activity-Based Screening Tests. |
| 000490 (2019) |
Lorna A. Nisbet [Royaume-Uni] ; Fiona M. Wylie [Royaume-Uni] ; Barry K. Logan [États-Unis] ; Karen S. Scott [États-Unis] | Gas Chromatography-Mass Spectrometry Method for the Quantitative Identification of 23 New Psychoactive Substances in Blood and Urine. |
| 000570 (2019) |
Catherine O. Brown [États-Unis] ; Barry K. Logan [États-Unis] ; Heather E. Mckiernan [États-Unis] | A survey of senior practitioners regarding most desirable qualifications for hiring and advancement within forensic science. |
| 000827 (2018) |
Marykathryn Tynon Moody [États-Unis] ; Stephanie Diaz [États-Unis] ; Parul Shah [États-Unis] ; Donna Papsun [États-Unis] ; Barry K. Logan [États-Unis] | Analysis of fentanyl analogs and novel synthetic opioids in blood, serum/plasma, and urine in forensic casework. |
| 000919 (2017) |
Marykathryn Tynon [États-Unis] ; Joseph Homan [États-Unis] ; Sherri Kacinko [États-Unis] ; Annette Ervin [États-Unis] ; Matthew Mcmullin [États-Unis] ; Barry K. Logan [États-Unis] | Rapid and sensitive screening and confirmation of thirty-four aminocarbonyl/carboxamide (NACA) and arylindole synthetic cannabinoid drugs in human whole blood. |
| 000948 (2017) |
Donna Papsun [États-Unis] ; Daniel Isenschmid [États-Unis] ; Barry K. Logan | Observed Carfentanil Concentrations in 355 Blood Specimens from Forensic Investigations. |
| 000979 (2017) |
Aileen Lu [États-Unis] ; Karen S. Scott [États-Unis] ; Aya Chan-Hosokawa [États-Unis] ; Barry K. Logan [États-Unis] | Impact of Expanding ELISA Screening in DUID Investigations to Include Carisoprodol/Meprobamate and Zolpidem. |
| 000B47 (2016) |
Laura M. Labay [États-Unis] ; James L. Caruso [États-Unis] ; Thomas P. Gilson [États-Unis] ; Rebecca Jufer Phipps [États-Unis] ; Laura D. Knight [États-Unis] ; Nikolas P. Lemos [États-Unis] ; Iain M. Mcintyre [États-Unis] ; Robert Stoppacher [États-Unis] ; Lee Marie Tormos [États-Unis] ; Andrea L. Wiens [États-Unis] ; Erica Williams [États-Unis] ; Barry K. Logan [États-Unis] | Synthetic cannabinoid drug use as a cause or contributory cause of death. |
| 000C92 (2016) |
Peter B. Chase [États-Unis] ; Jeff Hawkins [États-Unis] ; Jarrod Mosier [États-Unis] ; Ernest Jimenez [États-Unis] ; Keith Boesen [États-Unis] ; Barry K. Logan [États-Unis] ; Frank G. Walter [États-Unis] | Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs. |
| 000C98 (2016) |
Megan E. Slater [États-Unis] ; I-Jen P. Castle [États-Unis] ; Barry K. Logan [États-Unis] ; Ralph W. Hingson [États-Unis] | Differences in state drug testing and reporting by driver type in U.S. fatal traffic crashes. |
| 000D46 (2016) |
Donna Papsun [États-Unis] ; Alison Krywanczyk [États-Unis] ; James C. Vose [États-Unis] ; Elizabeth A. Bundock [États-Unis] ; Barry K. Logan [Oman] | Analysis of MT-45, a Novel Synthetic Opioid, in Human Whole Blood by LC-MS-MS and its Identification in a Drug-Related Death. |
| 000D73 (2015) |
Marykathryn Tynon [États-Unis] ; Marcellino Porto [États-Unis] ; Barry K. Logan [Oman] | Simplified analysis of 11-hydroxy-delta-9-tetrahydrocannabinol and 11-carboxy-delta-9-tetrahydrocannabinol in human meconium: method development and validation. |
| 000E41 (2015) |
Barry K. Logan [Oman] ; Amanda L Arntson Mohr [États-Unis] ; Stephen K. Talpins [États-Unis] | Response to "Comparison of urine to oral fluid and the recommendation for routine drug analysis for driving under the influence cases". |
| 001052 (2014) |
Shaza Deeb [Royaume-Uni] ; Denise A. Mckeown [Royaume-Uni] ; Hazel J. Torrance [Royaume-Uni] ; Fiona M. Wylie [Royaume-Uni] ; Barry K. Logan [États-Unis] ; Karen S. Scott [États-Unis] | Simultaneous analysis of 22 antiepileptic drugs in postmortem blood, serum and plasma using LC-MS-MS with a focus on their role in forensic cases. |
| 001441 (2012) |
Barry K. Logan [États-Unis] ; Lindsay E. Reinhold ; Allan Xu ; Francis X. Diamond | Identification of synthetic cannabinoids in herbal incense blends in the United States. |
| 001634 (2010) |
Barry K. Logan [États-Unis] ; Anthony G. Costantino ; Eric F. Rieders ; David Sanders | Trazodone, meta-chlorophenylpiperazine (an hallucinogenic drug and trazodone metabolite), and the hallucinogen trifluoromethylphenylpiperazine cross-react with the EMIT®II ecstasy immunoassay in urine. |
| 001811 (2009) |
Barry K. Logan [États-Unis] ; Gary Goldfogel ; Rebecca Hamilton ; James Kuhlman | Five deaths resulting from abuse of dextromethorphan sold over the internet. |
| 001834 (2009) |
Barry K. Logan [États-Unis] | Combined dextromethorphan and chlorpheniramine intoxication in impaired drivers. |
